Brain scans reveal how your diet may fuel obesity
NCT ID NCT05626907
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study investigates whether short-term diet changes cause inflammation in the hypothalamus, a brain region that controls body weight. Overweight adults aged 20-40 eat specially prepared meals for 14 days, alternating between high- and low-calorie periods. Researchers use MRI scans to measure signs of brain inflammation called gliosis. The goal is to understand how poor nutrition might lead to obesity through effects on the brain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- diet modification (controlled meals for 14 days with varying calorie levels)
- What this could lead to
- If it works, this could reveal how poor diet triggers brain inflammation that drives obesity, pointing toward new prevention strategies.
- What could go wrong
- This is a small, early-stage study with only 36 participants, so results may not apply broadly. It measures brain changes, not weight loss or health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EATING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Washington
Seattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test